Keep Westword Free

Marijuana legalization: Pharmaceutical firms eye potential market worth tens of billions

A March report from See Change Strategy LLC pegged the national medical marijuana market at $1.7 billion, with the market doubling in five years. Impressive, sure, but according to InvestorPlace.com, a prominent financial site, it's a relative drop in the bucket compared to the $10 billion to $100 billion market that could develop if the feds were to legalize marijuana outright.

In comparison, pharmaceutical powerhouse Pfizer earned $11 billion last year on the superstar drug Lipitor.

So who would profit from all those legal marijuana billions? Most likely, it would be those already profiting in the pharmaceutical industry. The federal Drug Enforcement Administration recently reported that it has granted pot-growing licenses to 55 companies; while those firms weren't named, InvestorPlace.com fingers such likely culprits as Watson Pharmaceuticals, which markets the THC drug Marinol, and Valeant Pharmceutical International, which has developed a different THC drug called Cesamet. Other candidates include Pfizer, Merck, GlaxoSmithKline, Bristol Myers-Squibb and the big pharma powerhouses looking to get into the THC game as early as possible.

I Support
  • Local
  • Community
  • Journalism
  • logo

Support the independent voice of Denver and help keep the future of Westword free.

Then there's Sativex, a marijuana drug that's different from the others because it's not synthetic: It's a liquefied sativa extract that contains both healthful cannabinoids and the psychoactive component THC -- although apparently the THC is limited enough that it will take quite the dose to get a person as high as, say, smoking a joint. It's likely that Sativex's developer, GW Pharmaceuticals, is angling for legal U.S. pot farms, too.

So what part of the market does that leave for the mom and pops if pot does becomes legal? Not a big slice -- although considering the rapid growth of Colorado's medical marijuana market, some hometown ganjapreneurs might end up giving Big Pharma a run for at least some of the money.

More from our Marijuana archive: "Medical marijuana seminar will offer tips on on how to profit from Colorado's cash crop"

Keep Westword Free... Since we started Westword, it has been defined as the free, independent voice of Denver, and we would like to keep it that way. Offering our readers free access to incisive coverage of local news, food and culture. Producing stories on everything from political scandals to the hottest new bands, with gutsy reporting, stylish writing, and staffers who've won everything from the Society of Professional Journalists' Sigma Delta Chi feature-writing award to the Casey Medal for Meritorious Journalism. But with local journalism's existence under siege and advertising revenue setbacks having a larger impact, it is important now more than ever for us to rally support behind funding our local journalism. You can help by participating in our "I Support" membership program, allowing us to keep covering Denver with no paywalls.

We use cookies to collect and analyze information on site performance and usage, and to enhance and customize content and advertisements. By clicking 'X' or continuing to use the site, you agree to allow cookies to be placed. To find out more, visit our cookies policy and our privacy policy.


Join the Westword community and help support independent local journalism in Denver.


Join the Westword community and help support independent local journalism in Denver.